💪Testosterone & Hormonal Support

The endogenous hypothalamic decapeptide that controls reproductive hormone release, used clinically for fertility treatment and diagnostics, and in TRT protocols to maintain testicular function.

A 10-amino acid fragment of kisspeptin that is the most potent endogenous stimulator of GnRH release, playing a critical role in reproductive hormone regulation and fertility.

A mitochondria-targeted tetrapeptide that concentrates in the inner mitochondrial membrane, protecting cardiolipin and restoring bioenergetics in aging and disease.

A mitochondria-derived peptide that acts as an exercise mimetic, improving metabolic health, insulin sensitivity, and physical performance through AMPK activation.

An FDA-approved synthetic analogue of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid modification, indicated for HIV-associated lipodystrophy and studied for cognitive benefits and visceral fat reduction.

A synthetic hexapeptide growth hormone secretagogue that stimulates GH release through the ghrelin receptor (GHS-R1a), notable for its potent GH-releasing effects and strong appetite stimulation.

A modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis and inhibits lipogenesis without the diabetogenic or growth-promoting effects of full-length HGH.

An investigational dual glucagon and GLP-1 receptor agonist being developed for obesity and MASH (metabolic dysfunction-associated steatohepatitis) with significant liver fat reduction.

A D-retro-inverso peptide that selectively induces apoptosis in senescent cells by disrupting the FOXO4-p53 interaction, representing a targeted senolytic approach to aging.

An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and obesity management, with cardiovascular and neuroprotective benefits.

An investigational triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, producing unprecedented weight loss of up to 24% in clinical trials.

An FDA-approved once-weekly GLP-1 receptor agonist for type 2 diabetes with proven cardiovascular benefits and convenient single-use pen delivery.

A 28-amino acid thymic peptide that modulates immune function, approved in multiple countries for hepatitis B and used as an immune enhancer in cancer and infectious disease.

A mitochondria-derived 24-amino acid peptide with potent cytoprotective and neuroprotective effects, being studied for Alzheimer's disease, metabolic health, and longevity.

A synthetic cyclic peptide analogue of alpha-melanocyte-stimulating hormone (α-MSH) that induces skin tanning, increases libido, and reduces appetite through melanocortin receptor activation.

A synthetic hexapeptide growth hormone secretagogue considered to offer the best balance of potency and side effect profile among the GHRP family.

A synthetic hexapeptide growth hormone secretagogue that potently stimulates GH release through the ghrelin receptor, with additional cardioprotective properties.

The first GLP-1 receptor agonist approved for type 2 diabetes, originally derived from Gila monster venom, available in twice-daily and once-weekly formulations.

An FDA-approved melanocortin receptor agonist that treats hypoactive sexual desire disorder (HSDD) in premenopausal women by acting directly on the central nervous system to increase sexual desire and arousal.